Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.4538
-0.0434 (-8.73%)
Jan 28, 2026, 12:37 PM EST - Market open
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $33.36 million as of January 28, 2026. Its market cap has decreased by -43.49% in one year.
Market Cap
33.36M
Enterprise Value
56.30M
1-Year Change
-43.49%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $33.36M, a decrease of -65.74%. That is a compound annual growth rate of -10.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 36.55M | -63.92% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 38.98M |
| OnKure Therapeutics | 38.61M |
| TuHURA Biosciences | 38.35M |
| Generation Bio Co. | 38.27M |
| Anebulo Pharmaceuticals | 37.39M |
| Celularity | 37.11M |
| Lantern Pharma | 36.46M |
| Genenta Science | 36.09M |